RT Journal Article
SR Electronic
T1 Evidence of integrated health service delivery during COVID-19 in low- and middle-income countries: protocol for a scoping review
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.23.20160721
DO 10.1101/2020.07.23.20160721
A1 Neill, Rachel
A1 Hasan, Md Zabir
A1 Das, Priyanka
A1 Venugopal, Vasuki
A1 Jain, Nishant
A1 Arora, Dinesh
A1 Gupta, Shivam
YR 2020
UL http://medrxiv.org/content/early/2020/08/03/2020.07.23.20160721.abstract
AB Introduction The importance of integrated, people-centered health systems has been recognized as a central component of achieving Universal Health Coverage. Integration has also been highlighted as a critical element for building resilient health systems that can stand the shock of health emergencies. However, there is dearth of research and systematic synthesis of evidence on the synergistic relationship between integrated health services and pandemic preparedness in low- and low-middle income countries (LMICs). Thus, the authors are organizing a scoping review aiming to explore application of integrated health service delivery approaches during the emerging COVID-19 pandemic in LMICs.Methods and analysis This scoping review adheres to the six steps for scoping reviews from Arksey and O’Malley (2005). Peer reviewed scientific literature will be systematically assembled utilizing a standardized and replicable search strategy from seven electronic databases, including PubMed, Embase, Scopus, Web of Science, CINAHL Plus, the World Health Organization’s Global Research Database on COVID-19, and LitCovid. Initially, the title and abstract of the collected literature, published in English from December 2019 to June 2020, will be screened for inclusion which will be followed by a full text review by two independent reviewers. Data will be charted using a data extraction form and reported in narrative format with accompanying data matrixes.Ethics and dissemination No ethical approval is required for the review. The study will be conducted from June to December 2020. Results from this study will provide a snapshot of the evidence currently being generated related to integrated health service delivery in response to the COVID-19 pandemic. The findings will be developed into reports and a peer-reviewed articles and will assist policy makers in making pragmatic and evidence-based decisions for current and future pandemic response.Strengths and limitations of this studyThe scoping review aims to uncover new evidence in response to the evolving pandemic and will not assess the quality of existing evidenceThe review will map a rapidly emerging evidence base in response to COVID-19 from seven different electronic databases that can be used to inform response and recovery strategies in LMICsThe early research and published evidence on the COVID-19 pandemic was focused in high-income and upper-middle income countries, thus, we expect evidence of from LMICs may be scarceThe scoping review is limited to peer review publications that were originally written in English or have translated versionsCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Indo German Social Security Programme, GIZ India Grant Number #81251835.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical review is not required for the scoping review. Only publicly available secondary data will be utilized for the review, and no primary data will be collected.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis study is developed from publicly available secondary data. The scoping review is registered on OSF.io with the Registration DOI 10.17605/OSF.IO/KY9PX (osf.io/yk7gu).